New Prescription Migraine Drugs Aren’t Resonating with Patients—Here’s How Pharma Can Boost Uptake
PM360
JUNE 29, 2022
The migraine therapy market has heated up over the past few years with the emergence of many new acute and preventive medications. However, patient uptake hasn’t matched rising market competition. Other influencing factors included more information on side effects (36%), drug cost (28%), and efficacy (28%).
Let's personalize your content